These studies have led many researchers to focus on inhibiting complement proteins to alleviate stroke injuries (109–112), including depletion of complement proteins, suppressing complement-driven cellular recruitment, neutralizing MBL, and inhibiting complement protein activation, among others. Here, MBL2 is linked to stroke disorder.